Neurosense Therapeutics Ltd Stock Price on December 12, 2024
| NRSNW Stock | USD 0.25 0.10 66.67% |
If you're considering investing in NeuroSense Stock, it is important to understand the factors that can impact its price. As of today, the current price of NeuroSense Therapeutics stands at 0.25, as last reported on the 12th of December 2024, with the highest price reaching 0.25 and the lowest price hitting 0.25 during the day. NeuroSense Therapeutics is out of control given 3 months investment horizon. NeuroSense Therapeutics has Sharpe Ratio of 0.21, which conveys that the firm had a 0.21% return per unit of risk over the last 3 months. We were able to interpolate twenty-seven different technical indicators, which can help you to evaluate if expected returns of 6.71% are justified by taking the suggested risk. Use NeuroSense Therapeutics Downside Deviation of 29.31, mean deviation of 17.17, and Risk Adjusted Performance of 0.1168 to evaluate company specific risk that cannot be diversified away.
At this time, NeuroSense Therapeutics' Common Stock Shares Outstanding is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to climb to about 5.3 M in 2024, whereas Other Stockholder Equity is likely to drop slightly above 18 M in 2024. . Price Earnings Ratio is likely to drop to -1.11 in 2024. Price Book Value Ratio is likely to climb to -5.43 in 2024. NeuroSense Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
NeuroSense |
Sharpe Ratio = 0.2078
| Best Portfolio | Best Equity | NRSNW | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 32.27 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.21 actual daily | 16 84% of assets perform better |
Based on monthly moving average NeuroSense Therapeutics is performing at about 16% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NeuroSense Therapeutics by adding it to a well-diversified portfolio.
Book Value (0.09) | Shares Float 13.5 M | Shares Short Prior Month 2.2 K | Earnings Share (0.94) | Shares Short 2 K |
NeuroSense Therapeutics Main Headline on 11th of December 2024
NeuroSense Therapeutics Receives Positive FDA Feedback on Ph... by news.google.com
NeuroSense Therapeutics Receives Positive FDA Feedback on Phase 3 Study Design for PrimeC Form 6 K Marketscreener.com
NeuroSense Therapeutics Valuation on December 12, 2024
It is possible to determine the worth of NeuroSense Therapeutics on a given historical date. On December 12, 2024 NeuroSense was worth 0.25 at the beginning of the trading date compared to the closed value of 0.25. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of NeuroSense Therapeutics stock. Still, in general, we apply an absolute valuation method to find NeuroSense Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of NeuroSense Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against NeuroSense Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 0.15 | 0.15 | 0.15 | 0.15 | 424.00 | |
12/11/2024 | 0.25 | 0.25 | 0.25 | 0.25 | 300.00 |
| Backtest NeuroSense Therapeutics | | | NeuroSense Therapeutics History | | | NeuroSense Therapeutics Valuation | Previous |
NeuroSense Therapeutics Trading Date Momentum on December 12, 2024
| On December 11 2024 NeuroSense Therapeutics Ltd was traded for 0.25 at the closing time. The highest daily price throughout the period was 0.25 and the lowest price was 0.25 . The daily volume was 300. The net trading volume on 12/11/2024 did not cause price change. The trading delta at closing time to current closing price is 0.00% . |
NeuroSense Therapeutics Fundamentals Correlations and Trends
By evaluating NeuroSense Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among NeuroSense Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. NeuroSense financial account trend analysis is a perfect complement when working with valuation or volatility modules.About NeuroSense Therapeutics Stock history
NeuroSense Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for NeuroSense is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in NeuroSense Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing NeuroSense Therapeutics stock prices may prove useful in developing a viable investing in NeuroSense Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 13.6 M | 14.3 M |
NeuroSense Therapeutics Stock Technical Analysis
NeuroSense Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
NeuroSense Therapeutics Period Price Range
Low | December 12, 2024
| High |
0.00 | 0.00 |
NeuroSense Therapeutics Ltd cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
NeuroSense Therapeutics December 12, 2024 Market Strength
Market strength indicators help investors to evaluate how NeuroSense Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NeuroSense Therapeutics shares will generate the highest return on investment. By undertsting and applying NeuroSense Therapeutics stock market strength indicators, traders can identify NeuroSense Therapeutics Ltd entry and exit signals to maximize returns
NeuroSense Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for NeuroSense Therapeutics' price direction in advance. Along with the technical and fundamental analysis of NeuroSense Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of NeuroSense to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1168 | |||
| Jensen Alpha | 4.54 | |||
| Total Risk Alpha | (0.28) | |||
| Sortino Ratio | 0.131 | |||
| Treynor Ratio | (0.77) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for NeuroSense Stock Analysis
When running NeuroSense Therapeutics' price analysis, check to measure NeuroSense Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeuroSense Therapeutics is operating at the current time. Most of NeuroSense Therapeutics' value examination focuses on studying past and present price action to predict the probability of NeuroSense Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeuroSense Therapeutics' price. Additionally, you may evaluate how the addition of NeuroSense Therapeutics to your portfolios can decrease your overall portfolio volatility.